Sarah Fischer is an associate in the firm’s IP Litigation Department and is a member of the firm’s Life Sciences Disputes group. She joined Goodwin in 2015.

Ms. Fischer focuses her practice on patent matters, including biotechnology, pharmaceuticals, medical devices, and software. Ms. Fischer’s experience includes representation of clients in district court litigation and before the Patent Trial and Appeal Board (PTAB).

Areas of Practice
Domaines D’Expertise





Ms. Fischer’s experience includes:

  • Shire Development LLC v. Actavis Laboratories FL, Inc. (D. Del.): Representing Actavis in a patent infringement litigation filed by Shire involving formulations of mixed salts of a single-entity amphetamine. The case is currently pending.
  • In re: Copaxone 775 Patent Litigation (D. Del.): Represented Teva in patent infringement litigation against multiple generic defendants involving patents directed to a process for manufacturing glatiramer acetate (Copaxone®).
  • Celltrion, Inc. v. Genetech, Inc. (P.T.A.B.) Represented Celltrion in several IPRs related to trastuzumab.
  • Incyte Corp. v. Concert Pharmaceuticals, Inc. (P.T.A.B.): Represented Concert in IPR matter involving deuterated analogs of ruxolitinib.
  • Pfizer Inc. v. Micro Labs USA Inc. (D. Del.): Represented Sun in patent infringement litigation filed by Pfizer involving extended release tofacitinib.
  • In re: Copaxone 40mg Consolidated Cases (D. Del.): Representing Teva in a patent infringement litigation against five generic manufacturers involving patents directed to the treatment of multiple sclerosis with a novel dosing regimen for the drug glatiramer acetate.
  • Tris Pharma Inc. v. Actavis Laboratories FL, Inc. (D. Del.): Represented Acavtis in victory over Tris Pharma in federal court in Delaware, paving the way for Actavis to launch a generic version of Quillivant XR® (methylphenidate hydrochloride), a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The Court found invalid five patents covering Quillivant®’s formulation and use, which would have protected the drug from generic competition for another 14 years.
Professional Activities

Ms. Fischer is a member of the Boston Bar Association.

Professional Experience

Following law school, Ms. Fischer served as a law clerk to the Honorable Ron Clark, Chief Judge of the U.S. District Court for the Eastern District of Texas.


Ms. Fischer graduated first in her class at Suffolk University Law School in 2013, where she was awarded the Daniel J. Fern Award for achieving the highest cumulative GPA in her class. She also received a Concentration in International Law with Distinction. While in law school, Ms. Fischer served as an articles editor for the Suffolk University Law Review. She is the author of “Yours, Mine or Ours: A Proposal for Sensible Reform of the Massachusetts Tenancy-by-the-Entirety Statute”, Note, 46 Suffolk U. L. Rev. 1133 (2013). Ms. Fischer was a member of Suffolk University Law School’s Jessup International Moot Court Team and Foreign Direct Investment Moot Team. She won the Suffolk Transnational Law Review International Moot Court Competition in both 2012 and 2013.

Ms. Fischer was named as a Super Lawyers 2020 Massachusetts Rising Star.

In The News









J.D., 2013
Suffolk University Law School

(summa cum laude)

M.A., Chemistry, 2010
Boston University
B.S., Chemistry, 2005
University of Massachusetts, Lowell

(summa cum laude)


2013 to 2015 U.S. District Court for the Eastern District of Texas, Honorable Ron Clark



New York
U.S. Patent and Trademark Office (USPTO)


U.S. District Court for the Eastern District of Texas
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique